FDA AI Credibility Framework: Impact on Research Tools
Analyze the FDA AI Credibility Framework and its impact on scientific research tools. Review the 7-step risk-based validation process for drug development.
Back to Articles
Articles tagged with “risk-based-validation”
FDA AI Credibility Assessment in Drug Development
Review the FDA's 7-step AI credibility assessment framework. Understand how to validate and document AI models for regulatory drug development submissions.
CSA vs CSV: Validating AI Systems Under FDA Guidance
Compare FDA's Computer Software Assurance (CSA) vs CSV for AI systems. Learn risk-based validation strategies for machine learning in life sciences.
CSV to CSA: Understanding FDA's New Validation Guidance
Analyze the transition from CSV to FDA's Computer Software Assurance (CSA). This guide details risk-based validation strategies and compliance impacts.
FDA CSA Guidance: A Pharma & Biotech Compliance Guide
Understand the FDA's final Computer Software Assurance (CSA) guidance, a risk-based shift from CSV for pharma & biotech. Learn key principles for compliance.
GAMP 5 & CSA: A Practical Integration Guide for Pharma
Learn how to integrate GAMP 5 (2nd Ed.) and Computer Software Assurance (CSA). This guide details the shift from CSV to a modern, risk-based validation strategy
GAMP 4 vs GAMP 5: Key Differences & Migration Guide
Learn the key differences between GAMP 4 and GAMP 5. Updated for 2026 with FDA's finalized CSA guidance, ISPE GAMP AI Guide, and EU GMP Annex 11/22 drafts. Clear migration path for pharma IT.